Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$88.85
0.020.02%
Pre-Market: 7:36 AM EDT
Comments
Loading...
HealthEquity Analyst Ratings and Price Targets | NASDAQ:HQY | Benzinga
HealthEquity Inc has a consensus price target of $106.47 based on the ratings of 18 analysts. The high is $130 issued by BTIG on November 14, 2024. The low is $76 issued by SVB Leerink on June 7, 2022. The 3 most-recent analyst ratings were released by Goldman Sachs, Raymond James, and Keybanc on March 27, 2025, March 25, 2025, and March 24, 2025, respectively. With an average price target of $106.33 between Goldman Sachs, Raymond James, and Keybanc, there's an implied 19.68% upside for HealthEquity Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
Raymond James
Keybanc
Barrington Research
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for HealthEquity
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/27/2025 | Buy Now | 5.8% | Goldman Sachs | David Roman37% | $107 → $94 | Maintains | Neutral | Get Alert |
| 03/25/2025 | Buy Now | 29.43% | Raymond James | C. Gregory Peters79% | $120 → $115 | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/24/2025 | Buy Now | 23.8% | Keybanc | Scott Schoenhaus44% | $120 → $110 | Maintains | Overweight | Get Alert |
| 03/19/2025 | Buy Now | 26.06% | Barrington Research | Alexander Paris82% | $112 → $112 | Maintains | Outperform | Get Alert |
| 03/14/2025 | Buy Now | 26.06% | Barrington Research | Alexander Paris82% | $112 → $112 | Maintains | Outperform | Get Alert |
| 02/26/2025 | Buy Now | 40.69% | Wells Fargo | Stan Berenshteyn42% | $110 → $125 | Maintains | Overweight | Get Alert |
| 02/25/2025 | Buy Now | 35.06% | Raymond James | C. Gregory Peters79% | $105 → $120 | Maintains | Outperform | Get Alert |
| 12/10/2024 | Buy Now | 20.43% | JMP Securities | Constantine Davides38% | $105 → $107 | Maintains | Market Outperform | Get Alert |
| 12/10/2024 | Buy Now | 18.18% | RBC Capital | Sean Dodge48% | $100 → $105 | Maintains | Outperform | Get Alert |
| 12/04/2024 | Buy Now | 41.81% | Mizuho | Steven Valiquette60% | → $126 | Initiates | → Outperform | Get Alert |
| 12/02/2024 | Buy Now | 35.06% | Barrington Research | Alexander Paris82% | $105 → $120 | Maintains | Outperform | Get Alert |
| 11/15/2024 | Buy Now | 21.55% | Goldman Sachs | David Roman37% | → $108 | Initiates | → Neutral | Get Alert |
| 11/14/2024 | Buy Now | 46.31% | BTIG | David Larsen44% | $110 → $130 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 35.06% | B of A Securities | Allen Lutz59% | $100 → $120 | Maintains | Buy | Get Alert |
| 09/20/2024 | Buy Now | 18.18% | Barrington Research | Alexander Paris82% | $105 → $105 | Maintains | Outperform | Get Alert |
| 09/04/2024 | Buy Now | 18.18% | Barrington Research | Alexander Paris82% | $105 → $105 | Maintains | Outperform | Get Alert |
| 09/04/2024 | Buy Now | 15.93% | Deutsche Bank | George Hill62% | $102 → $103 | Maintains | Buy | Get Alert |
| 09/04/2024 | Buy Now | 18.18% | JMP Securities | Constantine Davides38% | $105 → $105 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/04/2024 | Buy Now | 3.55% | RBC Capital | Sean Dodge48% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 09/04/2024 | Buy Now | 12.55% | B of A Securities | Allen Lutz59% | $105 → $100 | Maintains | Buy | Get Alert |
| 08/30/2024 | Buy Now | 18.18% | Barrington Research | Alexander Paris82% | $105 → $105 | Maintains | Outperform | Get Alert |
| 07/03/2024 | Buy Now | 18.18% | B of A Securities | Allen Lutz59% | $105 → $105 | Maintains | Buy | Get Alert |
| 06/20/2024 | Buy Now | 23.8% | Wells Fargo | Stan Berenshteyn42% | $107 → $110 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | 18.18% | Raymond James | C. Gregory Peters79% | $100 → $105 | Maintains | Outperform | Get Alert |
| 06/05/2024 | Buy Now | 12.55% | Keybanc | Scott Schoenhaus44% | $95 → $100 | Maintains | Overweight | Get Alert |
| 06/04/2024 | Buy Now | 20.43% | Wells Fargo | Stan Berenshteyn42% | $105 → $107 | Maintains | Overweight | Get Alert |
| 06/04/2024 | Buy Now | 18.18% | Barrington Research | Alexander Paris82% | $100 → $105 | Maintains | Outperform | Get Alert |
| 06/04/2024 | Buy Now | 3.55% | RBC Capital | Sean Dodge48% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 06/04/2024 | Buy Now | 18.18% | B of A Securities | Allen Lutz59% | $97 → $105 | Maintains | Buy | Get Alert |
| 06/04/2024 | Buy Now | 18.18% | JMP Securities | Constantine Davides38% | $101 → $105 | Maintains | Market Outperform | Get Alert |
| 06/04/2024 | Buy Now | 17.05% | Baird | Mark Marcon71% | $98 → $104 | Maintains | Outperform | Get Alert |
| 04/04/2024 | Buy Now | 13.67% | JMP Securities | Constantine Davides38% | → $101 | Initiates | → Market Outperform | Get Alert |
| 04/02/2024 | Buy Now | 21.55% | JP Morgan | Anne Samuel56% | $86 → $108 | Maintains | Overweight | Get Alert |
| 03/22/2024 | Buy Now | 6.92% | Keybanc | Scott Schoenhaus44% | $85 → $95 | Maintains | Overweight | Get Alert |
| 03/22/2024 | Buy Now | 12.55% | Barrington Research | Alexander Paris82% | → $100 | Maintains | Outperform | Get Alert |
| 03/20/2024 | Buy Now | 23.8% | BTIG | David Larsen44% | $100 → $110 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 3.55% | RBC Capital | Sean Dodge48% | $90 → $92 | Maintains | Outperform | Get Alert |
| 03/20/2024 | Buy Now | 9.17% | B of A Securities | Allen Lutz59% | $93 → $97 | Maintains | Buy | Get Alert |
| 02/23/2024 | Buy Now | 1.29% | RBC Capital | Sean Dodge48% | $77 → $90 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 17.05% | Barclays | — | $84 → $104 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | 6.92% | Raymond James | C. Gregory Peters79% | $90 → $95 | Maintains | Outperform | Get Alert |
| 12/06/2023 | Buy Now | 4.67% | Wells Fargo | Stan Berenshteyn42% | $89 → $93 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | -4.33% | Barrington Research | Alexander Paris82% | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 12/01/2023 | Buy Now | -17.84% | JP Morgan | Anne Samuel56% | $81 → $73 | Maintains | Overweight | Get Alert |
| 09/21/2023 | Buy Now | -2.08% | Baird | Mark Marcon71% | $79 → $87 | Upgrade | Neutral → Outperform | Get Alert |
| 09/07/2023 | Buy Now | -18.96% | Deutsche Bank | George Hill62% | $71 → $72 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | -4.33% | Barrington Research | Alexander Paris82% | $80 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | Buy Now | -13.34% | RBC Capital | Sean Dodge48% | $75 → $77 | Maintains | Outperform | Get Alert |
| 06/07/2023 | Buy Now | -20.09% | Deutsche Bank | George Hill62% | $69 → $71 | Maintains | Buy | Get Alert |
| 06/06/2023 | Buy Now | -15.59% | RBC Capital | Sean Dodge48% | → $75 | Reiterates | → Outperform | Get Alert |
| 06/01/2023 | Buy Now | -9.96% | Barrington Research | Alexander Paris82% | → $80 | Reiterates | Outperform → Outperform | Get Alert |
| 03/24/2023 | Buy Now | -22.34% | Deutsche Bank | George Hill62% | $72 → $69 | Maintains | Buy | Get Alert |
| 03/22/2023 | Buy Now | -9.96% | Barrington Research | Alexander Paris82% | → $80 | Reiterates | → Outperform | Get Alert |
| 03/22/2023 | Buy Now | -15.59% | RBC Capital | Sean Dodge48% | → $75 | Reiterates | → Outperform | Get Alert |
| 02/03/2023 | Buy Now | 0.17% | Wells Fargo | Stan Berenshteyn42% | $101 → $89 | Maintains | Overweight | Get Alert |
| 01/24/2023 | Buy Now | -18.96% | Deutsche Bank | George Hill62% | $68 → $72 | Maintains | Buy | Get Alert |
| 12/12/2022 | Buy Now | -4.33% | Raymond James | C. Gregory Peters79% | $75 → $85 | Maintains | Outperform | Get Alert |
| 12/07/2022 | Buy Now | 5.8% | Guggenheim | Sandy Draper72% | $89 → $94 | Maintains | Buy | Get Alert |
| 12/07/2022 | Buy Now | 13.67% | Wells Fargo | Stan Berenshteyn42% | $104 → $101 | Maintains | Overweight | Get Alert |
| 12/05/2022 | Buy Now | -15.59% | RBC Capital | Sean Dodge48% | $70 → $75 | Maintains | Outperform | Get Alert |
| 10/25/2022 | Buy Now | 17.05% | Wells Fargo | Stan Berenshteyn42% | $100 → $104 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | -13.34% | Goldman Sachs | Cindy Motz28% | $64 → $77 | Upgrade | Sell → Neutral | Get Alert |
| 09/16/2022 | Buy Now | -4.33% | Keybanc | Scott Schoenhaus44% | → $85 | Initiates | → Overweight | Get Alert |
| 09/13/2022 | Buy Now | 12.55% | Wells Fargo | Stan Berenshteyn42% | $95 → $100 | Maintains | Overweight | Get Alert |
| 09/12/2022 | Buy Now | -15.59% | Raymond James | C. Gregory Peters79% | $70 → $75 | Maintains | Outperform | Get Alert |
| 09/08/2022 | Buy Now | -23.47% | Deutsche Bank | George Hill62% | $67 → $68 | Maintains | Buy | Get Alert |
| 09/07/2022 | Buy Now | -24.59% | Baird | Mark Marcon71% | $47 → $67 | Maintains | Neutral | Get Alert |
| 07/12/2022 | Buy Now | -33.6% | Goldman Sachs | Cindy Motz28% | → $59 | Initiates | → Sell | Get Alert |
| 06/08/2022 | Buy Now | -24.59% | Deutsche Bank | George Hill62% | $66 → $67 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | -14.46% | SVB Leerink | Stephanie Davis40% | $67 → $76 | Maintains | Outperform | Get Alert |
| 04/11/2022 | Buy Now | 6.92% | Wells Fargo | Stan Berenshteyn42% | → $95 | Initiates | → Overweight | Get Alert |
| 04/07/2022 | Buy Now | 0.17% | Guggenheim | Sandy Draper72% | → $89 | Initiates | → Buy | Get Alert |
| 03/30/2022 | Buy Now | -4.33% | BTIG | David Larsen44% | → $85 | Upgrade | Neutral → Buy | Get Alert |
| 03/28/2022 | Buy Now | -9.96% | Jefferies | Glen Santangelo50% | $62 → $80 | Maintains | Buy | Get Alert |
FAQ
What is the target price for HealthEquity (HQY) stock?
The latest price target for HealthEquity (NASDAQ:HQY) was reported by Goldman Sachs on March 27, 2025. The analyst firm set a price target for $94.00 expecting HQY to rise to within 12 months (a possible 5.80% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HealthEquity (HQY)?
The latest analyst rating for HealthEquity (NASDAQ:HQY) was provided by Goldman Sachs, and HealthEquity maintained their neutral rating.
When was the last upgrade for HealthEquity (HQY)?
The last upgrade for HealthEquity Inc happened on March 25, 2025 when Raymond James raised their price target to $115. Raymond James previously had an outperform for HealthEquity Inc.
When was the last downgrade for HealthEquity (HQY)?
There is no last downgrade for HealthEquity.
When is the next analyst rating going to be posted or updated for HealthEquity (HQY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthEquity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthEquity was filed on March 27, 2025 so you should expect the next rating to be made available sometime around March 27, 2026.
Is the Analyst Rating HealthEquity (HQY) correct?
While ratings are subjective and will change, the latest HealthEquity (HQY) rating was a maintained with a price target of $107.00 to $94.00. The current price HealthEquity (HQY) is trading at is $88.85, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.